In animal models of conditions such as depression [88], Parkinson’s disease [18], and attention-deficit/hyperactivity disorder [89], LITUS has been demonstrated to increase BDNF levels in multiple brain areas, suggesting its potential in modulating neurotrophic support, thereby induce analgesic effect. The gene discussed is BDNF; the disease is depressive symptom measurement.